Accuracy of administrative claims data to identify dose specific rotavirus vaccination information: Implications for

Related Experiment Video

Updated: Apr 14, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.5K

Scott C Quinlan1, Stephan Lanes1, Crystal N Holick1

  • 1HealthCore, Inc., 800 Delaware Avenue, Fifth Floor, Wilmington, DE 19801, United States.

Vaccine
|April 19, 2015
PubMed

Insights

Administrative claims data show inaccuracies in vaccine records for RotaTeq (RV5) first doses. Approximately 13% of recorded RV5 vaccinations had errors in dose number or administration date, impacting data reliability.

Area of Science:

  • Vaccinology
  • Health Informatics
  • Pediatric Public Health

Background:

  • Vaccine administration data in claims databases often lacks verified accuracy.
  • Reliable vaccine records are crucial for public health surveillance and research.

Purpose of the Study:

  • To assess the accuracy of RotaTeq (RV5) vaccine administration information in administrative claims data.
  • To determine the extent of discrepancies between claims data and medical records for infant vaccinations.

Main Methods:

  • A retrospective cohort study was performed using the HealthCore Integrated Research Database(SM).
  • Infants receiving at least one RotaTeq (RV5) dose within their first year were identified.
  • Medical records were sampled to validate vaccine administration dates and dose information.

Main Results:

  • 169,560 infants received at least one RV5 dose.
  • Validation of medical records for 85 infants revealed that 74 (87.1%) had corresponding RV5 vaccination entries.
  • Discrepancies in administration date or dose number were noted for a subset of records.

Conclusions:

  • Administrative claims data demonstrated inaccuracies for approximately 13% of RotaTeq (RV5) first doses.
  • These findings highlight potential limitations in using claims data for precise vaccine administration tracking.
Abstract

Keywords:
Administrative claimsPositive predictive valueRotavirus vaccinationSafetyValidation

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.6K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.7K

Related Concept Videos

Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
533
Vaccinations01:51

Vaccinations

Overview
54.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886